Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Novel 64Cu-labeled antibody-conjugates designed to evade the endosomal-lysosomal pathway for increased intracellular radio-accumulation in target IL-5Rα-positive muscle invasive bladder cancer cells

Michel Paquette, Simon Beaudoin, Laurent Fafard-Couture, Angel Lopez, Roger Lecomte, Brigitte Guerin and Jeff Leyton
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 391;
Michel Paquette
1Universite de Sherbrooke Sherbrooke QC Canada
2Universite de Sherbrooke Sherbrooke QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Beaudoin
1Universite de Sherbrooke Sherbrooke QC Canada
2Universite de Sherbrooke Sherbrooke QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Fafard-Couture
1Universite de Sherbrooke Sherbrooke QC Canada
2Universite de Sherbrooke Sherbrooke QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angel Lopez
3University of South Australia Adelaide Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Lecomte
1Universite de Sherbrooke Sherbrooke QC Canada
2Universite de Sherbrooke Sherbrooke QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte Guerin
1Universite de Sherbrooke Sherbrooke QC Canada
2Universite de Sherbrooke Sherbrooke QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeff Leyton
1Universite de Sherbrooke Sherbrooke QC Canada
2Universite de Sherbrooke Sherbrooke QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 391

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Michel Paquette1,2,
  2. Simon Beaudoin1,2,
  3. Laurent Fafard-Couture1,2,
  4. Angel Lopez3,
  5. Roger Lecomte1,2,
  6. Brigitte Guerin1,2 and
  7. Jeff Leyton1,2
  1. 1Universite de Sherbrooke Sherbrooke QC Canada
  2. 2Universite de Sherbrooke Sherbrooke QC Canada
  3. 3University of South Australia Adelaide Australia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016200
Jun 20167500
Jul 20162400
Aug 2016400
Sep 20161100
Oct 20162000
Nov 20161100
Dec 20161400
Jan 20171800
Feb 2017900
Mar 2017700
Apr 20171000
May 20171300
Jun 20171300
Jul 2017300
Aug 2017200
Oct 2017300
Nov 2017300
Dec 2017300
Jan 2018300
Feb 2018100
Mar 2018100
Apr 2018200
May 2018300
Jun 20181200
Jul 2018300
Aug 2018300
Sep 2018100
Dec 2018100
Jan 2019200
Feb 2019300
Mar 2019100
Apr 2019100
May 2019400
Jun 2019200
Jul 2019200
Aug 2019100
Sep 20192400
Oct 2019400
Nov 2019200
Dec 2019500
Jan 2020300
Feb 2020500
Mar 20201400
Apr 20201200
May 2020300
Jun 2020400
Jul 2020400
Aug 20201200
Sep 20202200
Oct 2020500
Nov 20201300
Dec 2020600
Jan 2021300
Feb 2021700
Mar 20211900
Apr 20211900
May 2021800
Jun 2021400
Jul 20211200
Aug 20212500
Sep 2021800
Oct 20211500
Nov 20213600
Dec 20212400
Jan 20223900
Feb 20221400
Mar 2022900
Apr 20222100
May 20221700
Jun 2022200
Jul 2022100
Aug 2022200
Sep 2022300
Oct 2022300
Dec 2022300
Jan 2023200
Feb 2023900
Mar 2023200
Apr 2023300
May 2023500
Jun 2023200
Jul 2023100
Aug 2023200
Sep 2023300
Oct 2023100
Nov 2023200
Dec 2023300
Jan 2024400
Feb 2024100
Mar 2024100
Apr 20241000
May 2024700
Jun 2024400
Jul 2024300
Aug 2024900
Sep 2024800
Oct 2024400
Nov 2024300
Dec 2024500
Jan 2025100
Feb 2025400
Mar 20251000
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Novel 64Cu-labeled antibody-conjugates designed to evade the endosomal-lysosomal pathway for increased intracellular radio-accumulation in target IL-5Rα-positive muscle invasive bladder cancer cells
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Novel 64Cu-labeled antibody-conjugates designed to evade the endosomal-lysosomal pathway for increased intracellular radio-accumulation in target IL-5Rα-positive muscle invasive bladder cancer cells
Michel Paquette, Simon Beaudoin, Laurent Fafard-Couture, Angel Lopez, Roger Lecomte, Brigitte Guerin, Jeff Leyton
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 391;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Novel 64Cu-labeled antibody-conjugates designed to evade the endosomal-lysosomal pathway for increased intracellular radio-accumulation in target IL-5Rα-positive muscle invasive bladder cancer cells
Michel Paquette, Simon Beaudoin, Laurent Fafard-Couture, Angel Lopez, Roger Lecomte, Brigitte Guerin, Jeff Leyton
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 391;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Oncology-2

  • ImmunoPET of urokinase plasminogen activator (uPA) system: broad applicability in cancer imaging
  • Chelator-free radiolabeling: a new approach for graphene nanomaterials
  • Selective imaging of VEGFR-1 and VEGFR-2 receptors in orthotopic breast tumor using 89Zr-labeled receptor-specific VEGF mutants
Show more Preclinical Probes for Oncology-2

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire